-- シンライト・ミルク(NZE:SML、ASX:SM1)は、ブライト・デイリー&フードの利益減少につながった損失の大部分は1月に発生したもので、既に同社の半期決算に計上されていたと、ニュージーランド証券取引所への木曜日の提出書類で明らかにした。 シンライトは、ブライト・デイリーの第1四半期決算報告を受けてこの声明を発表した。ブライト・デイリーの報告では、シンライトの損失が主な原因で、同社の利益が前年同期比で大幅に減少したとされている。 シンライトは、1月の損失に加え、2月と3月にも比較的小幅な純損失を計上しており、これもブライト・デイリーの決算報告に反映されていると述べた。 シンライトのニュージーランド株は、木曜日の取引で1%以上上昇した。
Related Articles
Gentrack Group to Acquire Dubai Technology Partners in $10 Million Deal
Gentrack Group (ASX:GTK, NZE:GTK) signed an agreement to acquire Dubai-based airport technology and services provider Dubai Technology Partners for an enterprise value of $10 million, according to a Thursday filing with the Australian and New Zealand bourses.Dubai Technology Partners will be incorporated into the company's Veovo airports division, boosting its artificial intelligence-powered portfolio while also broadening its global footprint and strengthening its presence in the Middle East, per the filing.The deal, which will be funded through the company's existing cash reserves, is expected to add about NZ$3.5 million in fiscal 2026 revenue over four months post-completion, the filing said. It will also be marginally accretive to earnings before interest, taxes, depreciation, and amortization before integration costs, the filing added.The transaction is expected to be completed within a month, subject to standard conditions.The company's Australian shares were up 2% in recent Thursday trade, while its Kiwi shares added about 1%.
Avita Medical Says Wound Care System Preparation Method Receives Regulatory Approval in Australia, New Zealand
Avita Medical (ASX:AVH) said its RECELL GO wound care system preparation method received regulatory clearance in Australia and New Zealand, allowing for commercialization in both markets for burn and acute wound treatment, according to a Thursday Australian bourse filing.It secured certification from Australia's Therapeutic Goods Administration and was listed on New Zealand's Web Assisted Notification of Devices database by Medsafe.RECELL GO combines a reusable, electricity-powered RECELL processing device with a single-use RECELL preparation kit, with one such kit capable of treating wounds up to 1,920 square centimeters, per the filing.Its exclusive distribution partner in Australia and New Zealand, Revolution Surgical, expects to begin the commercial launch within the coming weeks.Its shares rose over 2% in recent trading on Thursday.
Dateline Resources Reports AU$96 Million Cash at Hand, Advances US Project BFS
Dateline Resources (ASX:DTR) completed a AU$50 million placement after the end of the March quarter, taking cash at hand, before costs, to AU$96 million to advance pre-construction activities at the Colosseum project in the US, according to a Thursday Australian bourse filing.The company said that the June quarter will see the release of the Colosseum gold bankable feasibility study and the rapid transition to project financing and planned construction, while exploration drilling will continue on the rare earths and gold targets at Colosseum with multiple rigs operating around the clock.At Music Valley, the geophysical interpretation will be used to guide the next phase of ground exploration, the filing added.